NOS2 and breast cancer: EGFR expression was strongly correlated with expressions of NOS2 (r= 0.287–0.388) in liver cancer, kidney cancer and, breast cancer, poorly correlated in head and neck cancer (r=0.082) but show no association (r = −0.001) in colon and lung cancer (Figure 5).